HDL metabolism in hypertriglyceridemic states: An overview

Clinica Chimica Acta

Volumn 286, Issue 1-2, 1999, Pages 145-161

  Lamarche, Benoit ^a   Rashid, Shirya ^b   Lewis, Gary F ^b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Apolipoprotein A I; Cholesteryl ester transfer protein; HDL cholesterol; Intravascular lipases; Kinetic studies; Triglycerides

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL ESTER TRANSFER PROTEIN; GEMFIBROZIL; HEPARIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

CARDIOVASCULAR RISK; CHOLESTEROL TRANSPORT; CONFERENCE PAPER; HEART PROTECTION; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RABBIT;

CHOLESTEROL, HDL; HUMANS; HYPERTRIGLYCERIDEMIA; PARTICLE SIZE;

EID: 0032838901     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00098-4     Document Type: Conference Paper

References (74)

1. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease: the Framingham study. Am J Med. 62:1977;707-714.
2. Miller N.E., Forde O.H., Thelle D.S., Mjos O.D. The Tromso Heart Study: high-density lipoprotein as a protective factor against coronary heart disease: a prospective case-control study. Lancet. 1:1977;965-967.
3. Castelli W.P., Doyles J.T., Gordon T. HDL-cholesterol and other lipids in coronary heart disease: the cooperative lipoprotein phenotyping study. Circulation. 55:1977;767-772.
4. Gordon D.J., Rifkind B.M. High density lipoprotein: the clinical implications of recent studies. N Engl J Med. 321:1989;1311-1316.
5. Reichl D., Miller N.E. Pathophysiology of reverse cholesterol transport. Insight from inherited disorders of lipoprotein metabolism. Arterioscler Thromb Vasc Biol. 9:1989;785-797.
6. Durrington P.N. How HDL protects against atheroma. Lancet. 342:1993;1315-1316.
7. Marcel Y.L., Vézina B., Teng B., Sniderman A.D. Transfer of cholesterol esters between human high density lipoproteins and triglyceride-rich lipoproteins controlled by a plasma protein factor. Atherosclerosis. 35:1980;127-133.
8. Tall A.R. Plasma cholesteryl ester transfer protein. J Lipid Res. 34:1993;1255-1274.
9. Saku K., Ahmad M., Glas-Greenwalt P., Kashyap M.L. Activation of fibrinolysis by apolipoproteins of high density lipoproteins in man. Thromb Res. 39:1985;1-8.
10. Satoh K., Imaizumi T.A., Yoshida H., Takamatsu S. High-density lipoprotein inhibits the production of platelet activating factor acetylhydrolase by HepG2 cells. J Lab Clin Med. 124:1994;225-231.
11. Mackness M.I., Durrington P.N. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis. 115:1995;243-253.
12. Spector A., Scanu A.M., Kaduce T.L., Figard P.H., Fless G.M., Czervionke R.L. Effect of human plasma lipoproteins on prostacyclin production by cultured endothelial cells. J Lipid Res. 26:1985;288-297.
13. Miller N.E., Weinstein D.B., Carey T.E., Koschinsky T., Steinberg D. Interaction between high density and low density lipoproteins during uptake and degradation by cultured human fibroblasts. J Clin Invest. 60:1987;78-89.
14. Lamarche B., Després J.P., Moorjani S., Cantin B., Dagenais G.R., Lupien P.J. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec Cardiovascular Study. Atherosclerosis. 119:1996;235-245.
15. Lamarche B., Després J.P., Pouliot M.C., Prud'homme D., Moorjani S., Lupien P.J., Nadeau A., Tremblay A., Bouchard C. Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arterioscler Thromb. 13:1993;33-40.
16. Eisenberg S. Lipoprotein abnormalities in hypertriglyceridemia: significance in atherosclerosis. Am Heart J. 113:1987;555-561.
17. Eisenberg S. Lipoproteins and lipoprotein metabolism. A dynamic evaluation of the plasma transport system. Klin Wochenschr. 61:1983;119-132.
18. Tall A.R. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest. 68:1990;379-384.
19. Brunzell J.D., Albers J.J., Chait A., Grundy S.M., Groszek E., McDonald G.B. Plasma lipoproteins in familial combined hypertriglyceridemia and monogenic familial hypertriglyceridemia. J Lipid Res. 24:1983;147-155.
20. Santamarina-Fojo S., Brewer H.B. Jr. Lipoprotein lipase: structure, function and mechanism of action. Int J Clin Lab Res. 24:1994;143-147.
21. Brewer H.B. Jr., Rader D.J. HDL: structure, function and metabolism. Prog Lipid Res. 30:1991;139-144.
22. Eisenberg S. High density lipoprotein metabolism. J Lipid Res. 25:1984;1017-1058.
23. Lewis G.E., Steiner G. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus. Diabetes Metab Rev. 12:1996;37-56.
24. Lewis G.E., O'Meara N.M., Soltys P.A., Blackman J.D., Iverius P.H., Pugh W.L., Getz G.S., Polonsky K.S. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein metabolism. J Clin Endocrinol Metab. 72:1991;934-944.
25. Chang L.B., Hopkins G.J., Barter P.J. Particle size distribution of high density lipoproteins as a function of plasma triglyceride concentration in human subjects. Atherosclerosis. 56:1985;61-70.
26. O'Meara N.M., Cabana V.G., Lukens J.R., Loharikar B., Forte T.M., Polonsky K.S., Getz G.S. Heparin-induced lipolysis in hypertriglyceridemic subjects results in the formation of atypical HDL particles. J Lipid Res. 35:1994;2178-2190.
27. Lewis G.E., O'Meara N.M., Soltys P.A., Blackman J.D., Iverius P.H., Druetzler A.F., Getz G.S., Polonsky K.S. Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test. J Clin Endocrinol Metab. 71:1990;1041-1050.
28. O'Meara N.M., Lewis G.F., Cabana V.G., Iverius P.H., Getz G.S., Polonsky K.S. Role of basal triglyceride and high density lipoprotein in determination of postprandial lipid and lipoprotein responses. J Clin Endocrinol Metab. 75:1992;465-471.
29. Grow T.E., Fried M. Lipoprotein geometry. II. Apoprotein exchange in human plasma high density lipoprotein. Biochem Biophys Res Commun. 75:1977;117-124.
30. Grow T.E., Fried M. Interchange of apoprotein components between the human plasma high density lipoprotein subclasses HDL2 and HDL3 in vitro. J Biol Chem. 253:1978;8034-8041.
31. Grow T.E. Factors affecting the exchange of apoproteins between human high density lipoprotein subclasses in vitro. Biochem Med. 29:1983;248-258.
32. Horowitz B.S., Goldberg I.J., Merab J., Vanni T.M., Ramakrishnan R., Ginsberg H.N. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J Clin Invest. 91:1993;1743-1752.
33. Glass C., Pittman R.C., Weinstein D.B., Steinberg D. Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonad. Proc Natl Acad Sci USA. 80:1983;5435-5439.
34. Brinton E.A., Eisenberg S., Breslow J.L. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler Thromb. 14:1994;707-720.
35. Nestel P.J. High-density lipoproteins turnover. Am Heart J. 113:1987;518-521.
36. Acton S., Rigotti A., Landschulz K.T., Xu S.Z., Hobbs H.H., Krieger M. Identification of scavenger receptors SR-BI as a high density lipoprotein receptor. Science. 271:1996;518-520.
37. Landschulz K.T., Pathak R.K., Rigotti A., Krieger M., Hobbs H.H. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J Clin Invest. 98:1996;984-995.
38. Schaefer E.J., Zech L.A., Jenkins L.L., Bronzert T.J., Rubalcaba E.A., Lindgren F.T., Aamodt R.L., Brewer H.B. Jr. Human apolipoprotein A-I and A-II metabolism. J Lipid Res. 23:1982;850-862.
39. Le N.A., Ginsberg H.N. Heterogeneity of apoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol. Metabolism. 37:1988;614-617.
40. Goldberg I.J., Blaner W.S., Vanni T.M., Moukides M., Ramakrishnan R. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys. J Clin Invest. 86:1990;463-473.
41. Golay A., Zech L.A., Shi M.Z., Chiou Y.A., Reaven G.M., Chen Y.D. High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL. J Clin Endocrinol Metab. 65:1987;512-518.
42. Frenais R., Ouguerram K., Maugeais C., Mahot P., Maugere P., Krempf M., Magot T. High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study. Diabetologia. 40:1997;578-583.
43. Schaefer E.J., Foster O.M., Jenkins L.L., Lindgren F.T., Berman M., Levy R.I., Brewer H.B. Jr. The composition and metabolism of high density lipoprotein subfractions. Lipids. 14:1979;511-522.
44. Saku K., Liu R., Ohta T., Jimi S., Matsuda I., Arakawa K. Plasma HDL levels are regulated by the catabolic rate of large particles of lipoprotein containing apo-A-I. Biochem Biophys Res Commun. 200:1994;557-561.
45. Skinner E.R. High-density lipoprotein subclasses. Curr Opin Lipidol. 5:1994;241-247.
46. Rader D.J., Castro G., Zech L.A., Fruchart J.C., Brewer H.B. Jr. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II. J Lipid Res. 32:1991;1849-1859.
47. Rader D.J., Ikewaki K. Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models. Curr Opin Lipidol. 7:1996;117-123.
48. Williams P.T., Krauss R.M., Vranizan K.M., Stefanick M.L., Wood P.D., Lindgren F.T. Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women. Arterioscler Thromb. 12:1992;332-340.
49. Li Z., McNamara J.R., Fruchart J.C., Luc G., Bard J.M., Ordovas J.M., Wilson P.W., Schaefer E.J. Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. J Lipid Res. 37:1996;1886-1896.
50. Funke H. Genetic determinants of high density lipoprotein levels. Curr Opin Lipidol. 8:1997;189-196.
51. Ishigami M., Yamashita S., Sakai N., Arai T., Hirano K., Hiraoka H., Kameda-Takemura K., Matsuzawa Y. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency cannot protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins. J Biochem Tokyo. 116:1994;257-262.
52. Ikewaki K., Rader D.J., Sakamoto T., et al. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. J Clin Invest. 92:1993;1650-1658.
53. Brousseau M.E., Santamarina-Fojo S., Vaisman B.L., Applebaum-Bowden D., Berard A.M., Talley G.D., Brewer H.B. Jr., Hoeg J.M. Overexpression of human lecithin:cholesterol acyltransferase in cholesterol-fed rabbits: LDL metabolism and HDL metabolism are affected in a gene dose-dependent manner. J Lipid Res. 38:1997;2537-2547.
54. Brousseau M.E., Santamarina-Fojo S., Zech L.A., Berard A.M., Vaisman B.L., Meyn S.M., Powell D., Brewer H.B. Jr., Hoeg J.M. Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner. J Clin Invest. 97:1996;1844-1851.
55. Glass C.K., Pittman R.C., Keller G.A., Steinberg D. Tissue sites of degradation of apoprotein A-I in the rat. J Biol Chem. 258:1983;7161-7167.
56. Sparks D.L., Davidson W.S., Lund Katz S., Phillips M.C. Effects of neutral lipid content of high density lipoprotein on apolipoprotein A-I and particle stability. J Biol Chem. 270:1995;26910-26917.
57. Meng Q.H., Sparks D.L., Marcel Y.L. Effect of LpA-I composition and structure on cholesterol transfer between lipoproteins. J Biol Chem. 270:1995;4280-4287.
58. Patsch J.R., Karlin J.B., Scott L.W., Smith L.C., Gotto A.M.J. Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci USA. 80:1983;1449-1453.
59. Beisiegel U. New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosis. Atherosclerosis. 124:1996;1-8.
60. Olivecrona G., Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opin Lipidol. 6:1995;291-305.
61. Lewis G.F., Cabana V.G., Lamarche B., Uffelman K.D., Getz G.S. Production of small HDL particles after intravenous heparin in hypertriglyceridemic diabetic and non-diabetic individuals. Studies before and after gemfibrozyl therapy. Metabolism. 47:1998;234-242.
62. Hegele R.A. The molecular basis of hepatic lipase deficiency. CMAJ. 145:1991;1277.
63. Hegele R.A., Vezina C., Moorjani S., Lupien P.J., Gagne C., Brun L.D., Little J.A., Connelly P.W. A hepatic lipase gene mutation associated with heritable lipolytic deficiency. J Clin Endocrinol Metab. 72:1991;730-732.
64. Fan J., Wang J., Bensadoun A., Lauer S.J., Dang Q., Mahley R.W., Taylor J.M. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci USA. 91:1994;8724-8728.
65. Busch S.J., Barnhart R.L., Martin G.A., Fitzgerald M.C., Yates M.T., Mao S.J., Thomas C.E., Jackson R.L. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J Biol Chem. 269:1994;16376-16382.
66. Newnham H.H., Hopkins G.J., Devlin S., Barter P.J. Lipoprotein lipase prevents the hepatic lipase-induced reduction in particle size of high density lipoproteins during incubation of human plasma. Atherosclerosis. 82:1990;167-176.
67. Clay M.A., Newnham H.H., Barter P.J. Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high density lipoproteins during incubation in vitro. Arterioscler Thromb. 11:1991;415-422.
68. Clay M.A., Newnham H.H., Forte T.M., Barter P.J. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta. 1124:1992;52-58.
69. Hayek T., Azrolan N., Verdery R.B., Walsh A., Chajek-Shaul T., Agellon L.B., Tall A.R., Breslow J.L. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. J Clin Invest. 92:1993;1143-1152.
70. Lamarche B., Uffelman K.D., Barrett H.R., Steiner G., Lewis G.F. Analysis of particle size and lipid composition as determinants of the metabolic clearance of human high density lipoproteins in a rabbit model. J Lipid Res. 39:1998;1162-1172.
71. Lewis G.F., Lamarche B., Uffelman K.D., Heatherington A.C., Honing M.A., Szeto L.W., Barrett H.R. Clearance of post-prandial and lipolytically modified human HDL in rabbits and rats. J Lipid Res. 38:1997;1771-1781.
72. Lamarche B., Uffelman K.D., Carpentier A., Steiner G., Barrett H.R., Lewis G.F. Triglyceride enrichment of HDL enhances the in vivo metabolic clearance of HDL apolipoprotein A-I in healthy men. J Clin Invest. 103:1999;1191-1199.
73. Lamarche B., Moorjani S., Lupien P.J., Cantin B., Bernard P.M., Dagenais G.R., Després J.P. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec Cardiovascular Study. Circulation. 94:1996;273-278.
74. Rigotti A., Trigatti B., Babitt J., Penman M., Xu S., Krieger M. Scavenger receptor B1 - a cell surface receptor for high density lipoprotein. Curr Opin Lipidol. 8:1997;181-188.